Den 15 januari i år trädde Cybersäkerhetslagen (”CSL”) i kraft. Life science-branschen är en av de högkritiska sektorer som omfattas. SwedenBIO presenterar här väsentliga punkter om lagen.
SwedenBIO co-arranged a successful matchmaking event together with SciLifeLab and Wallenberg National Program for Data-Driven Life Science (DDLS) on 12 February.
We reached out to three Swedish CEOs who attended this year’s JPM to get their impressions and experience of the world’s top life science conference.
SwedenBIO offers international activities and discounts to many conferences for its members. We’re gearing up for upcoming Swedish delegations to BIO International, Switzerland, and the Japan–Korea region, each offering unique platforms for collaboration, innovation, and global partnerships.
Successful drug development is rarely a solo journey. In a recent seminar hosted by SwedenBIO, industry veterans from Novo Nordisk, Sprint Bioscience, Cantargia, and Affibody pulled back the curtain on the complexities of deal-making, alliance management, and the strategic art of the "pivot."
SwedenBIO är undertecknare till ett offentligt-privat partnerskap som har lanserats för att påskynda den gröna omställningen inom svensk hälso- och sjukvård och life science.
Investors and company leaders reflected on lessons from JPMorgan Healthcare Week 2026 and the evolving outlook for the Swedish and European biotech ecosystem at the SwedenBIO Summit.
At the SwedenBIO Summit 2026, industry leaders explored the crucial question of how to effectively build and scale life science companies in Sweden.
Recognized for transforming Swedish scientific excellence into global medical impact and for serving as a bold guiding star in building commercial capacity toward global markets, Hansa Biopharma, won the SwedenBIO Award 2025.
Den svenska life science-branschen fortsätter sin expansion med ökad omsättning och framtidstro – och med ökad jämställdhet i toppskiktet, visar SwedenBIOs nya barometerrapport.
